Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Cohance Lifesciences Limited, is an unlisted public company incorporated on 06 July, 2020. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 3,499.94 cr and the total paid-up capital is INR 3,394.66 cr.
Cohance Lifesciences Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 1.78% over the previous year. At the same time, it's book networth has increased by 43.15%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
79.77%
135.95%
348.76%
103.53%
-18.8%
56.84%
10.39
6.06
7.45
5.4
5.01
-0.43
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(12)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | ||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Solvency + | ||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | ||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | ||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | ||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | ||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | ||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 1
Total Amount : 283.5 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 105.0 cr
Axis Bank Limited
No. of Loans: 2
Total Amount : 100.0 cr
INDUSIND BANK LIMITED
No. of Loans: 1
Total Amount : 50.0 cr
IndusInd Bank Limited
No. of Loans: 2
Total Amount : 38.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 20.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 15.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 10.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Shweta Jalan | 00291675 | 3 years |
| Director | Anil Kumar Chanana | 00466197 | 2 years |
| Director | Bhaskar Vemban Iyer | 00480341 | 2 years |
| Managing Director | Venkatanaga Kali Vara Prasada Raju Vetukuri | 07267366 | 2 years |
| Director | Pankaj Patwari | 08206620 | 4 years |
| Director | Abhijit Mangalmoy Mukherjee | 08610857 | 2 years |
| CS | Praneeth Abhishek Gunda | <HIDDEN> | 2 years |
| Kmp | Sudarsan Maddi | <HIDDEN> | 0 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| YES BANK LIMITED |
Active
|
6,269.4 Cr | 1 | Maharashtra |
| SUVEN PHARMACEUTICALS LIMITED |
Active
|
25.5 Cr | 3 | Telangana |
| BHARAT SERUMS AND VACCINES LIMITED |
Amalgamated
|
9.0 Cr | 4 | Maharashtra |
| ZCL CHEMICALS LIMITED |
Amalgamated
|
9.1 Cr | 5 | Maharashtra |
| RA CHEM PHARMA LIMITED |
Amalgamated
|
8.5 Cr | 7 | Andhra Pradesh |
| BHARAT SERUMS AND VACCINES LIMITED |
Active
|
73.1 L | 4 | Maharashtra |
| MANJUSHREE TECHNOPACK LIMITED |
Active
|
13.7 Cr | 2 | Karnataka |
| MODENIK LIFESTYLE PRIVATE LIMITED |
Active
|
34.4 Cr | 1 | Karnataka |
| MEDI ASSIST HEALTHCARE SERVICES LIMITED |
Active
|
35.1 Cr | 1 | Karnataka |
| HCL TECHNOPARKS LIMITED |
Amalgamated
|
1.0 Cr | 1 | Delhi |
| SERVACIO CONSULTING PRIVATE LIMITED |
Active
|
1.0 L | 1 | Haryana |
| DFM FOODS LIMITED |
Active
|
10.1 Cr | 1 | Delhi |
| CAMPUS ACTIVEWEAR LIMITED |
Active
|
152.7 Cr | 1 | Delhi |
| IGT SOLUTIONS PRIVATE LIMITED |
Active
|
407.2 Cr | 1 | Maharashtra |
| ROUTE MOBILE LIMITED |
Active
|
63.0 Cr | 1 | Maharashtra |
| COFORGE LIMITED |
Active
|
66.7 Cr | 1 | Delhi |
| THEMIS MEDICARE LIMITED |
Active
|
9.2 Cr | 1 | Gujarat |
| RPG LIFE SCIENCES LIMITED |
Active
|
13.2 Cr | 1 | Maharashtra |
| GIL LIFESCIENCES PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 1 | Telangana |
| INISPIRE HEALTHCARE SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| CASPER PHARMA PRIVATE LIMITED |
Active
|
26.1 Cr | 1 | Telangana |
| SAPALA ORGANICS PRIVATE LIMITED |
Active
|
12.5 Cr | 1 | Telangana |
| AVRA LABORATORIES PRIVATE LIMITED |
Amalgamated
|
7.0 Cr | 1 | Maharashtra |
| KEIMED PRIVATE LIMITED |
Active
|
6.8 Cr | 1 | Telangana |
| GOKALDAS INTIMATEWEAR PRIVATE LIMITED |
Amalgamated
|
30.5 Cr | 1 | Karnataka |
| APOLLO HEALTHCO LIMITED |
Active
|
2,884.9 Cr | 1 | Tamil Nadu |
| ADVENT INDIA PE ADVISORS PRIVATE LIMITED |
Active
|
2.2 Cr | 1 | Maharashtra |
| MANNE LABORATORIES PRIVATE LIMITED |
Amalgamated
|
12.9 Cr | 1 | Andhra Pradesh |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| RA CHEM PHARMA LIMITED | Andhra Pradesh | 1996 | ₹ 8.5 Cr |
The incorporation date of COHANCE LIFESCIENCES LIMITED is 06 July, 2020
The authorized share capital of COHANCE LIFESCIENCES LIMITED is INR ₹ 3,499.9 Cr.
The paid-up capital of COHANCE LIFESCIENCES LIMITED is INR ₹ 3,394.7 Cr.
The registered address of COHANCE LIFESCIENCES LIMITED is 215 Atrium, C Wing, 8th Floor, 819-821Andheri Kurla Road, Ch akala, Andheri East Mumbai Mumbai Maharashtra - 400093
The CIN number of COHANCE LIFESCIENCES LIMITED is U24100MH2020PLC402958.
Expand
Delete
Collapse
See
details
